nf h Search Results


92
Novus Biologicals nf h
Contingency table and performance of biomarkers in predicting poor outcome 6 months after cardiac arrest.
Nf H, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf h/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
nf h - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

96
Proteintech nf200 259
Contingency table and performance of biomarkers in predicting poor outcome 6 months after cardiac arrest.
Nf200 259, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nf200 259/product/Proteintech
Average 96 stars, based on 1 article reviews
nf200 259 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

98
AvesLabs neurofilament heavy chain
Contingency table and performance of biomarkers in predicting poor outcome 6 months after cardiac arrest.
Neurofilament Heavy Chain, supplied by AvesLabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neurofilament heavy chain/product/AvesLabs
Average 98 stars, based on 1 article reviews
neurofilament heavy chain - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

93
Neuromics antibody against neurofilament 200 kd nf200
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Antibody Against Neurofilament 200 Kd Nf200, supplied by Neuromics, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody against neurofilament 200 kd nf200/product/Neuromics
Average 93 stars, based on 1 article reviews
antibody against neurofilament 200 kd nf200 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

91
Novus Biologicals anti nf h
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Anti Nf H, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nf h/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
anti nf h - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

93
Novus Biologicals rabbit anti mouse neurofilament heavy chain nf h antibody
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Rabbit Anti Mouse Neurofilament Heavy Chain Nf H Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti mouse neurofilament heavy chain nf h antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
rabbit anti mouse neurofilament heavy chain nf h antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Novus Biologicals chicken anti nf h polyclonal antibody
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Chicken Anti Nf H Polyclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chicken anti nf h polyclonal antibody/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
chicken anti nf h polyclonal antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
Novus Biologicals nb300
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Nb300, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nb300/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
nb300 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
R&D Systems anti nefh af3108
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Anti Nefh Af3108, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nefh af3108/product/R&D Systems
Average 90 stars, based on 1 article reviews
anti nefh af3108 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Novus Biologicals anti neurofilament h nf h
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Anti Neurofilament H Nf H, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti neurofilament h nf h/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
anti neurofilament h nf h - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

94
Novus Biologicals anti neurofilament h nfh antibody
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Anti Neurofilament H Nfh Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti neurofilament h nfh antibody/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti neurofilament h nfh antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology monoclonal neurofilament
Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of <t>NF200,</t> CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.
Monoclonal Neurofilament, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal neurofilament/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
monoclonal neurofilament - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Contingency table and performance of biomarkers in predicting poor outcome 6 months after cardiac arrest.

Journal: Heliyon

Article Title: Serum spectrin breakdown product and neurofilament heavy in predicting outcome after cardiac arrest: A diagnostic accuracy study

doi: 10.1016/j.heliyon.2023.e22582

Figure Lengend Snippet: Contingency table and performance of biomarkers in predicting poor outcome 6 months after cardiac arrest.

Article Snippet: We used commercially available enzyme-linked immunosorbent assay kit for the SBDP145 (MBS7606325, MyBioSource, San Diego, CA, USA) and Nf-H (NBP2-78763, Novus Biologicals, Englewood, CO, USA) analyses.

Techniques:

Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of NF200, CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.

Journal: Arthritis and rheumatism

Article Title: Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint.

doi: 10.1002/art.34385

Figure Lengend Snippet: Figure 5. Confocal images showing that CFA-induced inflammation of the joint induces sprouting of NF200, CGRP, and GAP-43 nerve fibers in the synovium and this sprouting is substantially attenuated by anti-NGF therapy. Representative confocal images of NF200- and CGRP-labeled sensory nerve fibers and GAP-43–labeled sprouting nerve fibers (yellow/orange) and DAPI-labeled nuclei (blue) in 20-m–thick knee joint sections from sham (saline)–injected mice (A, D, and G), CFA-injected mice treated with vehicle (B, E, and H), and CFA-injected mice treated with anti-NGF (C, F, and I) are shown. In sham-injected mice, a low-level, regular pattern of innervation by NF200, CGRP, and GAP-43 fibers was observed in the synovial space of the knee joint. Twenty-eight days after the initial injection of CFA, a significant number of NF200, CGRP, and GAP-43 nerve fibers had sprouted and exhibited a disorganized appearance as compared to observations in joints treated with saline only. NF200, CGRP, and GAP-43 sprouted nerve fibers were localized in the synovium and were not observed in the meniscus. Administration of anti-NGF significantly reduced the density of NF200, CGRP, and GAP-43 nerve fibers in the synovium of the joints with CFA-induced arthritis. See Figure 4 for definitions.

Article Snippet: Frozen bone/knee joint sections were incubated with an antibody against calcitonin gene– related peptide (CGRP) (polyclonal rabbit anti-rat CGRP; 1:10,000) (catalog no. C8198; Sigma) to label unmyelinated and thinly myelinated primary afferent sensory nerve fibers, and an antibody against neurofilament 200 kd (NF200) (chicken anti-NF200; 1:5,000) (catalog no. CH22104; Neuromics) to label myelinated primary afferent sensory nerve fibers.

Techniques: Labeling, Saline, Injection

Figure 4. Anti–nerve growth factor (anti-NGF) reduces Freund’s complete adjuvant (CFA)–induced nerve sprouting of sensory and sympathetic nerve fibers but does not alter the aberrant neovascularization and macrophage infiltration in the arthritic joint. Twenty-eight days after initial injection of CFA, there were significant increases in the density of sensory nerve fibers as demonstrated by positivity for calcitonin gene–related peptide (CGRP) (A) and neurofilament 200 kd (NF200) (B), sympathetic nerve fibers as demonstrated by positivity for tyrosine hydroxylase (TH) (C), and nerve fibers undergoing sprouting as demonstrated by positivity for growth-associated protein 43 (GAP-43) (D), as well as increases in vascularization as demonstrated by CD31 vessels (E) and a significant influx of macrophages (CD68) (F), in the synovium of the arthritic joint. Administration of anti-NGF significantly reduced the density of CGRP and NF200 sensory, TH sympathetic, and GAP-43 sprouting nerve fibers in the synovium of the joints with CFA-induced arthritis. In contrast, preventive sequestration of NGF did not reduce the number or alter the density of the CFA-induced aberrant CD31 neovascularization or the number of CD68 macrophages in the synovium of the arthritic joint. Values are the mean SEM from 6 mice.

Journal: Arthritis and rheumatism

Article Title: Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint.

doi: 10.1002/art.34385

Figure Lengend Snippet: Figure 4. Anti–nerve growth factor (anti-NGF) reduces Freund’s complete adjuvant (CFA)–induced nerve sprouting of sensory and sympathetic nerve fibers but does not alter the aberrant neovascularization and macrophage infiltration in the arthritic joint. Twenty-eight days after initial injection of CFA, there were significant increases in the density of sensory nerve fibers as demonstrated by positivity for calcitonin gene–related peptide (CGRP) (A) and neurofilament 200 kd (NF200) (B), sympathetic nerve fibers as demonstrated by positivity for tyrosine hydroxylase (TH) (C), and nerve fibers undergoing sprouting as demonstrated by positivity for growth-associated protein 43 (GAP-43) (D), as well as increases in vascularization as demonstrated by CD31 vessels (E) and a significant influx of macrophages (CD68) (F), in the synovium of the arthritic joint. Administration of anti-NGF significantly reduced the density of CGRP and NF200 sensory, TH sympathetic, and GAP-43 sprouting nerve fibers in the synovium of the joints with CFA-induced arthritis. In contrast, preventive sequestration of NGF did not reduce the number or alter the density of the CFA-induced aberrant CD31 neovascularization or the number of CD68 macrophages in the synovium of the arthritic joint. Values are the mean SEM from 6 mice.

Article Snippet: Frozen bone/knee joint sections were incubated with an antibody against calcitonin gene– related peptide (CGRP) (polyclonal rabbit anti-rat CGRP; 1:10,000) (catalog no. C8198; Sigma) to label unmyelinated and thinly myelinated primary afferent sensory nerve fibers, and an antibody against neurofilament 200 kd (NF200) (chicken anti-NF200; 1:5,000) (catalog no. CH22104; Neuromics) to label myelinated primary afferent sensory nerve fibers.

Techniques: Adjuvant, Injection